The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Pathway to Stop Diabetes
Pathway to Stop Diabetes® is a bold, innovative initiative designed to radically transform diabetes research. Our Vision is simple yet revolutionary: find a new generation of brilliant scientists at the peak of their creativity, and provide them with freedom, flexibility and financial and professional resources to set them on the road to breakthrough discoveries.
This initiative enables scientists to advance not only their research, but also their careers. Pathway scientists have access to the Mentor Advisory Group, an annual Pathway symposia, select speaking opportunities, and innovative technologies, all designed to foster interactions and collaboration that will enable them to accelerate their research progress.
Pathway seeks to bring new investigators and new perspectives to diabetes research. Supporting scientists with different backgrounds and experience is critical to achieving that objective. Pathway accepts nominations for exceptional investigators with medical and scientific backgrounds who propose innovative basic, clinical, translational, behavioral, epidemiological and health services research relevant to any type of diabetes, diabetes-related disease state or complication. Pathway solicits nominations for candidates in all disciplines as applied to diabetes including medicine, biology, chemistry, computing, physics, mathematics and engineering. In addition, nomination of scientists from diverse backgrounds, including minority groups that are underrepresented in biomedical research, is strongly encouraged.
Each institution is allowed to submit one nomination (total) to any of our Pathway Awards.
- Duke Internal: June 15, 2022
- Application: August 1, 2022
Below is a brief summary of the eligibility requirements. Please read the FULL requirements on the American Diabetes Association site.
Initiator: Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship). For non-tenure track research positions, (research scientist, research associate) you may be eligible to be nominated if your institution can confirm that your current position is a mentored training position that is not independent (i.e., you are fully supported by your mentor and your employment is dependent upon your mentor).
Accelerator: Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
Initiator Awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs), Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1,625,000.
The Pathway Accelerator Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.
Owing to the sponsor's restriction on the number of applications that may be submitted from Duke, anyone wishing to pursue nomination should submit the following materials by email to VDBS@duke.edu:
- NIH Biosketch
- Letter of support: for Initiator applications, from postdoc mentor; for Accelerator applications, from department chair
- Scientific abstract (250 word max)
- Specific aims (1 page max) – typically includes key background, relevance/significance, and Specific Aims
- Please identify which pathway (Initiator or Accelerator) you are applying to